In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
British Journal of Pharmacology2013Vol. 171(6), pp. 1392–1407
Citations Over TimeTop 1% of 2013 papers
Bogna M. Ignatowska‐Jankowska, Sudeshna Ghosh, Molly S. Crowe, Steven G. Kinsey, Micah J. Niphakis, Rehab A. Abdullah, Tao Qing, S T O' Neal, D. Matthew Walentiny, Jenny L. Wiley, Benjamin F. Cravatt, Aron H. Lichtman
Abstract
This article is part of a themed section on Cannabinoids 2013. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-6.
Related Papers
- → New Insights into Endocannabinoid Degradation and its Therapeutic Potential(2006)117 cited
- → Overview of the Chemical Families of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors(2008)77 cited
- → Alteration of endocannabinoid system in human gliomas(2011)63 cited
- → Expression of endocannabinoid synthetic enzyme mRNAs is correlated with cannabinoid 1 receptor mRNA in the mouse brain(2007)5 cited
- → Endocannabinoid System: Overview and Therapeutic Relevance(2021)